Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: Incidence of late-onset sepsis and neurological outcome

Journal of Perinatology

Volumn 31, Issue 1, 2011, Pages 63-69

  Romeo, M G ^a   Romeo, D M ^a   Trovato, L ^a   Oliveri, S ^a   Palermo, F ^a   Cota, F ^b   Betta, P ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

neurological assessment; preterms; Probiotics

Indexed keywords

AMIKACIN; AMPHOTERICIN B LIPID COMPLEX; IMIPENEM; MEROPENEM; PROBIOTIC AGENT; SULTAMICILLIN; TEICOPLANIN; VANCOMYCIN;

ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDIASIS; CONTINUOUS INFUSION; DIET SUPPLEMENTATION; DRUG DOSAGE FORM COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; FUNGAL COLONIZATION; GASTROINTESTINAL INFECTION; HUMAN; INFANT; INFECTION PREVENTION; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEWBORN SEPSIS; PICHIA GUILLIERMONDII; PREMATURITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

CANDIDIASIS; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MALE; MYCOSES; NERVOUS SYSTEM DISEASES; NEUROLOGIC EXAMINATION; PROBIOTICS; PROSPECTIVE STUDIES;

EID: 78650766074     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2010.57     Document Type: Article

References (42)

1. Makhoul IR, Kassis I, Smolkin T, Tamir A, Sujov P. Review of 49 neonates with acquired fungal sepsis. Pediatrics 2001; 107: 61-66.
2. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B, In Collaboration with the Israel Neonatal Network. Epidemiological, clinical and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: A national survey. Pediatrics 2002; 109: 34-39.
3. Makhoul IR, Bental Y, Weisbrod M, Sujov P, Lusky A, Reichman B. Candida versus bacterial late-onset sepsis in very low birth weight infants in Israel: A national survey. J Hosp Infect 2007; 65: 237-243.
4. Gaynes RP, Edwards JR, Jarvis WR, Culver DH, Tolson JS, Martone WJ. Nosocomial infections among neonates in high-risk nurseries in the United States. Pediatrics 1996; 98: 357-361.
5. Rabalais GP, Samiec TD, Bryant KK, Lewis JJ. Invasive candidiasis in infant weighing more than 2500 grams at birth admitted to a neonatal intensive care unit. Pediatric Infect Dis J 1996; 15: 348-352.
6. Smith H, Congdon P. Neonatal systemic candidiasis. Arch Dis Child 1985; 60: 365-3695.
7. Pappu-Katikaneni LD, Rao KP, Banister E. Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants. Mycoses 1990; 33: 20-23.
8. Gewold IH, Schwalbe RS, Taciak VL, Harrison TS, Panigrahi P. Stool microflora in extremely low birth weight infants. Arch Dis Child Fetal Neonatal Ed 1999; 80: F167-F173.
9. Kennedy MJ, Volz PA. Ecology of Candida albicans gut colonization: Inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infect Immun 1985; 49: 654-663.
10. Saiman L, Ludington E, Dawson JD, Patterson JE, Rangel-Frausto S, Wiblin RT, National Epidemiology of Mycoses Study Group. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 2001; 20(12): 1119-1124.
11. Tancrède C. Role of human microflora in health and disease. Eur J Clin Microbiol Infect Dis 1992; 11: 1012-1015.
12. Hammerman C, Bin-Nun A, Kaplan M. Germ warfare: Probiotics in defence of premature gut. Clin Perinat 2004; 31: 489-500.
13. Cummings JH, Macfarlane GT. Colonic microflora: Nutrition and health. Nutrition 1997; 13: 476-478.
14. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotcs in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 2001; 357: 1076-1079.
15. Neish AS. The gut microflora and intestinal epithelial cells: A continuing dialogue. Microbes Infect 2002; 4: 309-317.
16. Millar MR, Bacon C, Smith SL, Walker V, Hall MA. Enteral feeding of premature infants with Lactobacillus GG. Arch Dis Child 1993; 69: 483-487.
17. Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 2004; 70(2): 1176-1181.
18. Benjamin DK, Stoll BJ, Fanaroff AA, Mc Donald SA, Poole K, Laptook A et al. Neonatal Candidiasis among extremely low birth weight infants: Risk factors, mortality rates and neurodevelopment outcomes at 18 to 22 months. Pediatrics 2006; 117: 84-92.
19. Ziegler EE, Thureen PJ, Carlson SJ. Aggressive nutrition of very low birthweight infant. Clin Perinatol 2002; 29: 225-244.
20. Tsang RC, Uauy R, Koletzko B, Zlotkin SH. Nutrition of the preterm infant. Scientific Basis and Pratical Guidelines. Digital Educational Publishing: Cincinnati, 2005.
21. Savino F, Pelle E, Palumeri E, Oggero R, Miniero R. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: A prospective randomized study. Pediatrics 2007; 119(1): 124-130.
22. Gray JW. Surveillance of infection in neonatal intensive care units. Early Hum Develop 2007; 83: 157-163.
23. Oliveri S, Trovato L, Betta P, Romeo MG, Nicoletti G. Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients. Clin Microbiol Infect 2008; 14: 377-397 Research Notes 391.
24. Manzoni P, Pedicino R, Stolfi I, Decembrino L, Castagnola E, Pugni L, et al., the Neonatal Fungal Infections Task Force of the Italian Neonatology Society. Criteri per una corretta Diagnosi delle Infezioni Fungine Sistemiche Neonatali in TIN: I suggerimenti della Task Force per le Infezioni Fungine Neonatali del G.S.I.N. Pediatr Med Chir 2004; 26(2): 89-95.
25. Karvonen A, Casas I, Vesikari T. Safety and possible antidiarrhoeal effect of the probiotic Lactobacillus reuteri after oral administration to neonates. Clin Nutr 2001; 20(suppl 3): 63: Abstract 216.
26. Ramesh A, Nidhi S, Rama C, Ashok D, Vinod KP, Ira GH et al. Effect of oral Lactobacillus GG on Entyeric Microflora in low birth-weight neonates. JPGN 2003; 36: 397.
27. Pappas PG, Rex JH, Sobel JD, Filler SD, Dismukes WE, Walsh TJ et al. Guidelines for treatment of Candidiasis. Clin Infect Dis 2004; 38: 161.
28. Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in verylow- birth-weight infant. Clin Microbiol Rev 2004; 17: 638-680.
29. Haataja L, Mercuri E, Regev R, Cowan F, Rutherford M, Dubowitz V et al. Optimality score for the neurologic examination of the infant at 12 and 18 months of age. J Pediatr 1999; 135: 153-161.
30. Larroque B, Marret S, Ancel P, Arnaud C, Marpeau L, Supernant K et al. White matter damage and intraventricular hemorrhage in very preterm infants: The epipage study. J Pediatr 2003; 143: 477-483.
31. Kitajima H, Sumida Y, Tanaka R, Yuki N, Takayama H, Fujimura M. Early administration of Bifidobacterium breve to preterm infants: Randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 1997; 76: F101-F107.
32. Manzoni P, Mostert M, Leonessa ML, Priolo C, Farina D, Monetti C et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: A randomized study. Clin Infect Dis 2006; 42(12): 1735-1742. Epub 2006 May.
33. Wagner RD, Pieron C, Warner T, Dohnalek M, Farmer J, Roberts L et al. Biotherapeutic effect of probiotic bacteria on candidiasis in immunodeficient mice. Infect Immun 1997; 65: 4165-4172.
34. Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 2004; 70: 1176-1181.
35. Cukrowska B, LodInova-ZadnIkova R, Enders C, Sonnenborn U, Schulze J, Tlaskalové - Hogenové H. Specific proliferative and antibody responses of premature infants to intestinal colonization with non-pathogenic probiotic E. coli strain Nissle 1917. Scand J Immunol 2002; 55: 204-209.
36. Mountzouris KC, McCartney AL, Gibson GR. Intestinal microflora of human infants and current trends for its nutritional modulation. Br J Nutr 2002; 87: 405-420.
37. Reuman PD, Duckworth DH, Smith KL, Kagan R, Bucciarelli RL, Ayoub EM. Lack of effect of Lactobacillus GG on gastrointestinal bacterial colonization in premature infants. Pediatr Infect Dis J 1986; 5: 663-668.
38. De Vecchi E, Nicola L, Zanini S, Drago L. In vitro screening of probiotic characteristics of some Italian products. J Chemother 2008; 20(3): 341-347.
39. Indrio F, Riezzo G, Raimondi F, Bisceglia M, Cavallo L, Francavilla R. The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. J Pediatr 2008; 152(6): 801-806.
40. Haroon Parupia MF, Dhanireddy R. Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopaty of prematurity and progression to laser therapy in extremely low-birth-weight infants. J Perinatol 2001; 21(4): 242-247.
41. Wilson-Costello D, Walsh MC, Langer JH, Guillet R, Laptook AR, Stoll BJ, et al., for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: Effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants. Pediatrics 2009; 123: E430-e437.
42. Stoll B, Hansen N, Adams-Chapman I, Fanaroff A, Hintz S, Vohr B et al. Neurodevelopmental and growth impairnment among extremely low birth weight infants with neonatal infection. JAMA 2004; 292: 2357-2365.